Medical Innovation Exchange

Frosty funding forecast forces Finch to stop phase 3 trial, lay off 95% of staff and seek buyers for assets

https://www.fiercebiotech.com/biotech/frosty-funding-forecast-forces-finch-stop-phase-3-trial-lay-95-staff-and-seek-buyers-assets

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!